Dump that painkiller and try these alternative approaches
Medications for pain relief have been surrounded by a lot of controversy in recent years. Take the case of the drug rofecoxib, marketed under the name Vioxx by Merck & Co. of the US for treatment of pain ranging from arthritic to menstrual. In September 2004, faced with concerns about increased risk of heart attack and stroke...
Mumbai University wants to get listed. The idea is too hairbrained and too radical to work
The 150-year-old Mumbai University wants to go public. It has already appointed Deutsche Bank as the lead manager to explore the idea. The university budget passed in early April has a Rs 2-lakh provision to prepare a feasibility report on listing the university. Listing by unusual businesses is not...
The massive Indian bull-run over the last few years has led to swelling assets under management (AUM) of mutual funds. In the four equity categories, AUM at the end of March 2007 were up by 21% over the same period last year. The fastest growth, albeit on a small base, happened to index funds. From Rs219.61 crore in March 2006, assets managed by index funds shot up by 181% to Rs617.56...
